Australia Approves Leqembi for Early Alzheimer's TreatmentBusiness NewsWed 24 Sept 2025 09:32 CESTAustralia Approves Leqembi for Early Alzheimer's TreatmentAustralia's medical authority has approved the substance lecanemab, which is sold under the name Leqembi, as a treatment for early Alzheimer's, writes the Swedish company Bioarctic in a press release.
Australia Approves Leqembi for Early Alzheimer's TreatmentBusiness NewsWed 24 Sept 2025 09:32 CESTAustralia Approves Leqembi for Early Alzheimer's TreatmentAustralia's medical authority has approved the substance lecanemab, which is sold under the name Leqembi, as a treatment for early Alzheimer's, writes the Swedish company Bioarctic in a press release.
Business NewsWed 24 Sept 2025 07:23 CESTSBAB Reduces Savings Interest Rate for Private and Corporate Customers
Business NewsWed 24 Sept 2025 03:46 CESTAnna Breman Faces Challenges as New Zealand's Central Bank Governor
Business NewsTop NewsTue 23 Sept 2025 12:10 CESTInterest Rate Cut May Signal Time to Fix Mortgage Rates
Business NewsTop NewsTue 23 Sept 2025 09:30 CESTSwedish Central Bank Completes Interest Rate Cuts, Eyes Future Hikes
Business NewsTue 23 Sept 2025 08:27 CESTByggnads Sues Lithuanian Firm for 100 Million Kronor Over Wage Dispute
Business NewsMon 22 Sept 2025 10:18 CESTDanish Consumer Confidence Drops Amid Novo Nordisk Challenges